Compare Novartis AG (NVS) vs State Street PDR S&P Retail ETF (XRT) Price & Performance

Novartis AGTrade

State Street PDR S&P Retail ETFTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs State Street PDR S&P Retail ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while State Street PDR S&P Retail ETF trades at $88.47. The key difference: Novartis AG pays a 3.17% dividend while State Street PDR S&P Retail ETF pays none. Which is the better fit depends on your goals.

	NVS	XRT
Market Cap	$290.25B	—
Sector	Health	Broad Market / Factor
52-Week High	$168.62	$90.88
52-Week Low	$113.50	$77.28
Enterprise Value	$330.27B	—
Dividend Yield	3.17%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novartis AG

No Aura AI signal available yet.

State Street PDR S&P Retail ETF

XRT trades at $88.94, down 0.54% today, with a bullish technical outlook from moving averages but neutral oscillators. Recent retail sales data shows five consecutive months of growth, supporting the ETF's consumer discretionary exposure. The fund offers diversified retail sector access but lacks specific valuation metrics in current data.

The ETF benefits from sustained consumer spending trends but faces headwinds from inflation and weak sentiment. Technical strength suggests near-term upside potential, though overbought RSI signals caution. Risks include macroeconomic pressures and sector volatility.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 22 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

XRT

Inflation cools in June with consumer confidence rising, but energy and geopolitical risks threaten gains.ETF Trends · 1 day agoNeutral View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About State Street PDR S&P Retail ETF

XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.